Quick-Neuron™ Cholinergic – Human iPSC-Derived Neurons (Healthy Donor)
Quick-Neuron™ human iPSC-derived cholinergic neurons are off-the-shelf neurons that provide a consistent, biologically relevant in vitro model of human cholinergic neuronal function. These cryopreserved, ready-to-use iPSC-derived neurons mature rapidly in culture and deliver reproducible performance for studying cholinergic signaling, synaptic activity, neuronal network development, neurodegenerative disease research, drug discovery, and neurotoxicity screening.
$850.00
Advantages of iPSC-Derived Cholinergic Neurons
Cholinergic Neuron Protocol
Explore our detailed differentiation protocols, a step-by-step guide designed to simplify and optimize your laboratory procedures using our iPSC-derived cells and differentiation kits. These protocols leverage the latest advancements in iPSC technology to ensure efficient and reproducible results.
Cholinergic neuron morphology is confirmed via phase contrast imagery: Representative phase contrast images of Quick-Neuron™ Cholinergic – Human iPSC-derived Neurons on days 1-3 post-thaw. (scale bar = 100 μm)
Cholinergic Neuron Characterization
Cholinergic Neuron Marker Expression
Merge
TUBB3
ChAT
Nuclei
iPSC-derived cholinergic neurons express neuronal markers and display typical neurite growth. Immunofluorescent staining of Quick-Neuron™ Cholinergic – Human iPSC-derived Neurons on Day 3 post-thaw that shows expression of the pan-neuronal marker TUBB3 and the cholinergic neuron marker ChAT.
Additional Cholinergic Neuron Data
ALS Disease Study
Healthy Control
74 yr, Female, Caucasian
ALS Patient
62 yr, Female, Caucasian
ALS Disease Study: Healthy control and ALS patient-derived iPSCs were differentiated into cholinergic neurons. The cells were fixed at day 10 from iPSCs and stained by TUBB3 (Green) and TDP-43 (Red).
Neurite Length Analysis
Neurite Length Analysis: Our fast differentiation enables quick and quantitative comparison between healthy and patient or treated and non-treated cultures.
Product Specifications
| Parameters | Specifications |
|---|---|
| Product Name | Quick-Neuron™ Cholinergic - Human iPSC-Derived Neurons |
| Catalog No. | CH-SeV-HC-CW50065 |
| Product Components | Cryopreserved cells, Component N1, Component A, and Component P |
| Starting Material | iPSCs derived from peripheral blood mononuclear cells (CIRM line CW50065) |
| Storage Conditions | Frozen cells should be stored in liquid nitrogen (vapor phase). The rest of the components should be stored at -20°C. |
| Cell Type | Cholinergic Neurons |
| Culture Type | Feeder Cell-Free |
| Disease | Healthy Donor |
| Donor Sex | Female |
| Donor Age at Sampling | 74 |
| Donor Race Ethnicity | Caucasian, not Latino |
| Patient History | See Resources for more information. |
| Reprogramming Method | Episomal vector |
| Induction Method | Transcription factors delivered by Sendai virus |
| Growth Properties | Adherent |
| Number of viable cells | > 1.0 million viable cells per vial upon thawing |
| Cell viability and remaining live cells |
>70% at day 1, >211 live cells per mm2 >50% at day 7, >211 live cells per mm2 |
| Differentiation |
>80% TUBB3 positive cells >50% ChAT positive cells among TUBB3 positive cells |
| Sterility | No growth observed |
| Mycoplasma | No mycoplasmal enzymes detected |
| Morphological Observation | Cells are adherent and neurites exhibit substantial outgrowth, elongation and branching, indicative of a differentiated phenotype. |
| Restricted Use | For research use only. Not for use in diagnostic or therapeutic procedures. |
Cholinergic Neuron Resources
Quick-Neuron™ Cholinergic – Human iPSC-Derived Neurons
Quick-Neuron™ Cholinergic – SeV Kit
Induction of specific neuron types by overexpression of single transcription factors.
Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons
Tools to Study Neurodegeneration: iPSC-derived Neurons, Nerve Organoids, and Synaptogenic Beads
Related Products
FAQs
Does Quick-Tissue™ technology leave a genetic footprint?
Sendai virus (SeV) is an RNA virus, so it does not integrate into the genomic DNA. In principle, a foreign gene introduced intracellularly in the form of RNA is quickly translated and expressed because, unlike DNA, RNA does not need to enter the nucleus for forced expression, thereby providing no chance of mutagenesis. This is discussed in the following review paper: Yamamoto, et al., (2009) “Current prospects for mRNA gene delivery.” Eur. J. Pharm Biopharm 71, 484-489.
Will SeV remain active after differentiation?
No. The SeV used in our kits is a temperature-sensitive mutant that is active at 33℃ but becomes inactive at 37℃, which is the temperature instructed in the user guides post-differentiation.
Is Sendai virus (SeV) dangerous?
SeV is not pathogenic to humans (i.e., humans are not the natural host of the virus) and the infection does not persist in immunocompetent animals. Furthermore, SeV used in our kits does not produce infectious viral particles upon transduction to host hPSCs and is a temperature-sensitive mutant, such that it is active at 33℃ but becomes inactive at 37℃. However, because SeV can be transmitted by aerosol and contact with respiratory secretions and is highly contagious, appropriate care must be taken to prevent potential mucosal exposure to the virus. Our SeV-based kits must be used under Biosafety Level 2 (BL-2) containment with a biological safety cabinet or a laminar flow hood and with appropriate personal protective equipment. In the event that the virus comes into contact with skin or eyes, decontaminate the affected area by flushing with plenty of water and follow the safety manual prepared by your laboratory and approved by your Institutional Biosafety Committee.
Do I need a license agreement for any of Ricoh Biosciences’ products?
No. You don’t need any licence or material transfer agreement (MTA) to use our differentiation kits or iPSC-derived cells. However, please be advised that these products are for research use only.
Contact Us
Have a question about our products, services, or custom projects? Our team is here to help—reach out and we’ll get back to you as soon as possible.
Subscribe
By signing up you are agreeing to our Privacy Policy


